Zydus Lifesciences Buyback Latest News Today

February 10, 2024 2:54:00 PM

Zydus Life buyback 2024, Zydus Lifesciences buyback 2024: Zydus Lifesciences, formerly known as Cadila Healthcare, has approved a buyback of equity shares at its board meeting held this Friday.

March 28, 2024 7:06:00 PM

Zydus Lifesciences share price was up marginally in the early trade on March 28 despite the company receiving four observations from United States Food and Drug Administration (USFDA). At 9.31 am ...

February 13, 2024 2:17:00 PM

Zydus Lifesciences formed strong bullish candlestick ... Zydus Life Q3 results: The Board approved buy-back of upto Rs. 6000 million at Rs. 1005 per equity share (25% premium to closing share ...

January 8, 2024 12:11:00 PM

Zydus Lifesciences is based in India and engages in the sector 'Manufacturing'. Find out more about Zydus Lifesciences in our report focusing on the company's key figures and information.

March 15, 2024 3:30:00 AM

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

March 6, 2024 6:26:00 AM

Zydus Lifesciences Buyback: The last date to apply for the pharmaceutical company Zydus Lifesciences buyback is today on March 6. The company had announced its plan earlier this year in February.

April 16, 2024 6:30:00 AM

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

February 24, 2022 4:08:00 PM

Zydus Lifesciences on Monday said it has launched a generic medication to treat overactive bladder in the US market. The company has launched Mirabegron extended-release tablets in strength of 25 ...

July 11, 2022 6:09:00 PM

Seamless reading experience. Save your favourite. After grappling with severe shortages last year, Covax, the WHO-backed sharing initiative supplying Covid vaccine to low-to-middle-income ...

March 22, 2024 3:30:00 AM

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...